Latest AbioMed Stories
Reportlinker.com announces that a new market research report related to the Medical devices industry is available in its catalogue.
Abiomed, Inc. (NASDAQ: ABMD) announced today that Michael R. Minogue, Chairman, President and Chief Executive Officer, will present at the UBS Global Life Sciences Conference on Monday, September 22, 2008 at 10:30 a.m. ET. The conference will be held at the Grand Hyatt in New York City, New York.
Abiomed, Inc. (NASDAQ: ABMD) announced today that Michael R. Minogue, Chairman, President and Chief Executive Officer, will present at the Morgan Stanley Global Healthcare Unplugged Conference on September 9, 2008 at 9:45 a.m. ET.
Abiomed, Inc. (NASDAQ: ABMD) today announced the completion of the public offering of 2,419,932 shares of its common stock at $17.3788 per share. The net proceeds to Abiomed from the offering were approximately $41.7 million, after deducting the underwriting discount and estimated offering expenses.
Abiomed, Inc. (NASDAQ: ABMD) today announced first quarter of fiscal 2009 revenue of $16.4 million, up 16% compared to revenue of $14.1 million for the same period of fiscal 2008. Recent financial and operating highlights include: -- On June 2, 2008, Abiomed announced that it had received U.S.
Abiomed, Inc. (NASDAQ: ABMD) announced today that on Thursday, August 7, 2008, the Company will release first fiscal quarter 2009 results. The Company will host a conference call to discuss the results on Thursday, August 7, 2008, at 8:00 a.m. ET. Michael R.
Abiomed, Inc. (NASDAQ: ABMD) formally announced the results of its ImpellaÂ® 2.5 PROTECT I safety trial for the first time at the Cardiovascular Research Foundation's (CRF) annual Transcatheter Cardiovascular Therapeutics (TCT) Scientific Symposium and main sessions.
By Lisa Richwine WASHINGTON (Reuters) - Seriously ill heart failure patients expected to live only a month and ineligible for transplant can get an implant of a permanent artificial heart, U.S. health officials ruled on Tuesday.
The artificial heart, a mechanical heart replacement, is typically used in order to bridge the time to heart transplant or to replace the heart in case a transplant is impossible. Often ventricular assist devices are confused with mechanical hearts because the assist the heart through pumps. They are also different from a cardiopulmonary bypass machine which is an external device used to provide the function of the heart and lungs. CPBs are usually only used for a few hours at a time,...
- In dressmaking, straps running from the belt in front over the shoulders to the belt in the back, with more or less elaboration of trimming and outline. They usually broaden at the shoulder and narrow toward the waist.